Sponsor:
Cerevel Therapeutics, LLC
Code:
NCT04958031
Conditions
Apathy in Dementia
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
CVL-871 1.0 mg
CVL-871 3.0 mg
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations